Go to deals
Consumer & Retail | Healthcare

Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Founded in 1997, Groupe Nature distributes organic health products, mainly food supplements and cosmetics, through organic specialty shops, pharmacies and online.

Also founded in 1997, Winco is a reference distributor in the French parapharmacy market.

Oaklins’ team in France advised Groupe Nature on the acquisition of Winco.

Service
M&A buy-side
Parties
“We are very proud to integrate Winco into our group and we thank the Oaklins personal care and nutrition team for its commitment and expertise in achieving this transaction, which will allow us to extend our distribution channels to the health food industry and to develop Winco’s health product offering into the organic sector.”

Laurent Ducrocq

CEO, Groupe Nature

Talk to the deal team

Ludovic Beaulieu

Ludovic Beaulieu

Senior Advisor
Paris, France
Oaklins France
View profile Get in touch

Related deals

Kaviari has received a minority investment from idiCo
Consumer & Retail

Kaviari has received a minority investment from idiCo

Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.

Learn more
AWC has acquired a significant minority stake in MyFitness
Consumer & Retail

AWC has acquired a significant minority stake in MyFitness

AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more